N@N

Vikram Purohit Reiterated (ASND) at Hold and Held Target at $109 on, Aug 1st, 2023

Vikram Purohit of Morgan Stanley, Reiterated "Ascendis Pharma A/S" (ASND) at Hold and Held Target at $109 on, Aug 1st, 2023.

Vikram has made no other calls on ASND in the last 4 months.

There are 6 other peers that have a rating on ASND. Out of the 6 peers that are also analyzing ASND, 2 agree with Vikram's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Tiago Fauth of "Credit Suisse" Initiated at Hold and Held Target at $89 on, Wednesday, June 14th, 2023
• Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, April 5th, 2023

These are the ratings of the 4 analyists that currently disagree with Vikram

---

• Andreas Argyrides of "Wedbush" Reiterated at Buy and Held Target at $187 on, Wednesday, June 7th, 2023
• Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $152 on, Thursday, June 1st, 2023
• David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $146 on, Wednesday, April 5th, 2023
• Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $92 on, Tuesday, April 4th, 2023

Contributing Sources

---